FdaApplication
NDA 220934
Identifiers
- fda_app_no: NDA220934
Properties
| Property | Value |
|---|---|
| applicant_name | ELI LILLY AND CO |
| application_type | NDA |
| approval_date | 2026-04-01 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 5.5MG BASE | TABLET;ORAL |
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 14.5MG BASE | TABLET;ORAL |
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 2.5MG BASE | TABLET;ORAL |
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 9MG BASE | TABLET;ORAL |
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 0.8MG BASE | TABLET;ORAL |
| FOUNDAYO | ORFORGLIPRON CALCIUM | EQ 17.2MG BASE | TABLET;ORAL |
6 products